Back to Search
Start Over
P635: AN UPDATE OF SAFETY AND EFFICACY RESULTS FROM PHASE 1 STUDY OF LP‐108, A NOVEL AND SELECTIVE BCL‐2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMAS.
- Source :
- HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 7
- Database :
- Complementary Index
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- 176093982
- Full Text :
- https://doi.org/10.1097/01.HS9.0000969444.32459.0c